Belite Bio, Inc BLTE
Set alert
155.42 USD +1.75 +1.14%
As of Nov 3, 10:18 AM ET
154.41 Day range 156.90
102.00 52-week range 200.00
- YTD
- -2.84%
- 1 year
- +38.27%
- Open
- 156.01
- Prev close
- 153.67
- Mkt cap
- 6.26B
- Vol
- 38.05K
- Avg vol
- 177.40K
- EPS
- -2.74
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 154.41
- High
- 156.90
- Forward P/E
- 68.00
- Beta
- -1.19
- Short ratio
- 7.77
- Inst. own
- 24.27%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 161.47
- 200-d avg
- 160.36
- 1y target
- 227.44
Held by funds
12 US ETFs and mutual funds hold BLTE · largest positions
Ownership
Held by insiders 43.67%
Held by institutions 24.27%
Float held by institutions 43.08%
Institutions 99
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Darwin Global Management, Ltd. | 7.64% | 3,077,219 | 472.88M | Jun 29, 2026 |
| Paradigm Biocapital Advisors LP | 3.06% | 1,232,877 | 189.46M | Jun 29, 2026 |
| RTW Investments LP | 1.78% | 715,332 | 109.93M | Jun 29, 2026 |
| Millennium Management Llc | 1.23% | 494,564 | 76.00M | Jun 29, 2026 |
| Maverick Capital Ltd. | 0.98% | 396,311 | 60.90M | Jun 29, 2026 |
| Eventide Asset Management LLC | 0.97% | 390,829 | 60.06M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 0.97% | 390,829 | 60.06M | Jun 29, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.20% | 80,462 | 12.36M | Jun 29, 2026 |
| SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Emerging Markets ETF | 0.07% | 30,052 | 4.62M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 0.02% | 6,727 | 1.03M | Aug 30, 2026 |
| T. ROWE PRICE Eqy. SERIES, INC.-T. Rowe Price Health Sciences PORT. | 0.01% | 5,400 | 829.82K | Jun 29, 2026 |
| Fidelity Concord Street Trust-Fidelity ZERO International Index Fund | 0.01% | 5,934 | 911.88K | Aug 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHEN WAN-SHAN | Director | Sale | Apr 8, 2026 | 9,096 |
| CHUANG HAO-YUAN | Chief Financial Officer | Sale | Sep 7, 2026 | 26,038 |
| LIN YU-HSIN | Chief Executive Officer | Sale | Sep 7, 2026 | 70,134 |
| MATA NATHAN L. | Officer | Sale | May 6, 2026 | 0 |
| SCHOLL HENDRIK PETER | Officer | Sale | Sep 30, 2026 | 0 |